Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

[A study on hepatic iron overload in chronic hepatitis C patients].

Bomfim EA, Pereirade de Oliveira AC, Paraná R, Schinoni MI.

Acta Gastroenterol Latinoam. 2013 Sep;43(3):212-7. Spanish.

PMID:
24303687
2.

Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.

Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, Alberti A.

J Viral Hepat. 2006 Mar;13(3):199-205.

PMID:
16475996
3.

[Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].

Coral G, de Mattos AA, de Mattos AZ, dos Santos DE.

Arq Gastroenterol. 2006 Oct-Dec;43(4):265-8. Portuguese.

4.

Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.

Adinolfi LE, Utili R, Andreana A, Tripodi MF, Marracino M, Gambardella M, Giordano M, Ruggiero G.

Dig Dis Sci. 2001 Aug;46(8):1677-83.

PMID:
11508667
5.

Correlation of serum adiponectin levels and hepatic steatosis in hepatitis C virus genotype 1 infection.

Kara B, Gunesacar R, Doran F, Kara IO, Akkiz H.

Adv Ther. 2007 Sep-Oct;24(5):972-82.

PMID:
18029322
6.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x. Epub 2009 Apr 28.

PMID:
19413693
7.

Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.

El Ray A, Asselah T, Moucari R, El Ghannam M, Taha AA, Saber MA, Akl M, Atta R, Shemis M, Radwan AS, Ghali A, Paradis V, Marcellin P.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):421-7. doi: 10.1097/MEG.0b013e32835c9f69.

PMID:
23470266
8.

Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.

D'Souza RF, Feakins R, Mears L, Sabin CA, Foster GR.

Aliment Pharmacol Ther. 2005 Mar 1;21(5):519-24.

9.
10.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

PMID:
16511772
11.

Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C.

Fernández Salazar LI, Alvarez Gago LI, Aller de la Fuente R, Orduña Domingo A, Arranz Santos T, de la Calle Valverde F, del Olmo Martín L, de Luis Román D, González Hernández JM.

Rev Esp Enferm Dig. 2004 Dec;96(12):818-28. English, Spanish.

12.

Serum iron levels and hepatic iron overload in nonalcoholic steatohepatitis and chronic viral hepatitis.

Uraz S, Aygun C, Sonsuz A, Ozbay G.

Dig Dis Sci. 2005 May;50(5):964-9.

PMID:
15906776
13.

Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.

Rafi H, Kabbaj N, Salihoun M, Amrani L, Acharki M, Guedira M, Nya M, Amrani N.

Arab J Gastroenterol. 2011 Sep;12(3):136-8. doi: 10.1016/j.ajg.2011.07.003. Epub 2011 Sep 15.

PMID:
22055591
14.

Association between age at diagnosis and degree of liver injury in hepatitis C.

Oliveira AC, Bortotti AC, Nunes NN, El Bacha IA, Parise ER.

Braz J Infect Dis. 2014 Sep-Oct;18(5):507-11. doi: 10.1016/j.bjid.2014.04.003. Epub 2014 Jun 4.

15.

Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.

Silva IS, Perez RM, Oliveira PV, Cantagalo MI, Dantas E, Sisti C, Figueiredo-Mendes C, Lanzoni VP, Silva A, Ferraz ML.

J Gastroenterol Hepatol. 2005 Feb;20(2):243-8.

PMID:
15683427
16.

Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.

Petit JM, Benichou M, Duvillard L, Jooste V, Bour JB, Minello A, Verges B, Brun JM, Gambert P, Hillon P.

Am J Gastroenterol. 2003 May;98(5):1150-4.

PMID:
12809841
17.

[Is APRI score a suitable tool for prediction of fibrosis in Tunisian patients with genotype 1 chronic viral hepatitis C?].

Karoui S, Ben Romdhane S, Serghini M, Ben Mustapha N, Boubaker J, Haouet S, Filali A.

Tunis Med. 2012 Apr;90(4):282-5. French.

18.

Factors associated with liver steatosis and fibrosis in chronic hepatitis C patients.

Cholet F, Nousbaum JB, Richecoeur M, Oger E, Cauvin JM, Lagarde N, Robaszkiewicz M, Gouérou H.

Gastroenterol Clin Biol. 2004 Mar;28(3):272-8.

19.

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.

Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L.

Gut. 2005 Jul;54(7):1003-8.

20.

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

Hui JM, Kench J, Farrell GC, Lin R, Samarasinghe D, Liddle C, Byth K, George J.

J Gastroenterol Hepatol. 2002 Aug;17(8):873-81.

PMID:
12164963

Supplemental Content

Support Center